BioEquity Europe DigitalOxford Global’s Online Drug Discovery WeekJefferies Virtual Healthcare Conference 2021Precision in Drug Discovery & Preclinical.
Seelos Therapeutics to Participate in the 2021 Jefferies Virtual Healthcare Conference
Seelos Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 2021 Jefferies Virtual Healthcare Conference, June 1-4, 2021 . Raj Mehra, Ph.D., Chairman and CEO, will present on Thursday, June 3rd at 10:30am ET and host 1×1 meetings. Presentation webcast registration …
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 2021 Jefferies Virtual Healthcare Conference, June 1-4, 2021 .
Encompass Health to participate in the William Blair Annual Growth Stock Conference and Jefferies Virtual Healthcare Conference
News provided by
Share this article
Share this article
BIRMINGHAM, Ala., May 7, 2021 /PRNewswire/ Encompass Health Corp. (NYSE: EHC) today announced it will participate in William Blair s 41st Annual Growth Stock Conference and Jefferies Virtual Healthcare Conference. Both conferences will be held virtually the first week of June 2021.
Encompass Health s President and Chief Executive Officer Mark Tarr, EVP and Chief Financial Officer Doug Coltharp, and EVP and President of Inpatient Hospitals Barb Jacobsmeyer will participate in a fireside chat at the William Blair Annual Growth Stock Conference. The presentation will be held Wednesday, June 2, 2021 at 4:20 p.m. EDT.